View in EDS

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.

Saved in:
Bibliographic Details
Title: Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Authors: Sworder BJ; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Kurtz DM; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA., Alig SK; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Shukla N; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Garofalo A; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Macaulay CW; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Shahrokh Esfahani M; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Olsen MN; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Hamilton J; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Hosoya H; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Hamilton M; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA., Spiegel JY; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Baird JH; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Sugio T; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Carleton M; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Craig AFM; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Younes SF; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Sahaf B; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Sheybani ND; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Schroers-Martin JG; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Liu CL; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Oak JS; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Jin MC; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Beygi S; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Hüttmann A; Department of Hematology, University Hospital of Essen, Essen, Germany., Hanoun C; Department of Hematology, University Hospital of Essen, Essen, Germany., Dührsen U; Department of Hematology, University Hospital of Essen, Essen, Germany., Westin JR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Khodadoust MS; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA., Natkunam Y; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Majzner RG; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA 94305, USA., Diehn M; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA; Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA., Miklos DB; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address: arasha@stanford.edu.
Source: Cancer cell [Cancer Cell] 2023 Jan 09; Vol. 41 (1), pp. 210-225.e5. Date of Electronic Publication: 2022 Dec 29.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36584673
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sworder+BJ%22">Sworder BJ</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Kurtz+DM%22">Kurtz DM</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Alig+SK%22">Alig SK</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Frank+MJ%22">Frank MJ</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Shukla+N%22">Shukla N</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Garofalo+A%22">Garofalo A</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Macaulay+CW%22">Macaulay CW</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Shahrokh+Esfahani+M%22">Shahrokh Esfahani M</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Olsen+MN%22">Olsen MN</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+J%22">Hamilton J</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Hosoya+H%22">Hosoya H</searchLink>; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+M%22">Hamilton M</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Spiegel+JY%22">Spiegel JY</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Baird+JH%22">Baird JH</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Sugio+T%22">Sugio T</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Carleton+M%22">Carleton M</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Craig+AFM%22">Craig AFM</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Younes+SF%22">Younes SF</searchLink>; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Sahaf+B%22">Sahaf B</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Sheybani+ND%22">Sheybani ND</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Schroers-Martin+JG%22">Schroers-Martin JG</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Liu+CL%22">Liu CL</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Oak+JS%22">Oak JS</searchLink>; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Jin+MC%22">Jin MC</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Beygi+S%22">Beygi S</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Hüttmann+A%22">Hüttmann A</searchLink>; Department of Hematology, University Hospital of Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Hanoun+C%22">Hanoun C</searchLink>; Department of Hematology, University Hospital of Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Dührsen+U%22">Dührsen U</searchLink>; Department of Hematology, University Hospital of Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Westin+JR%22">Westin JR</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Khodadoust+MS%22">Khodadoust MS</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Natkunam+Y%22">Natkunam Y</searchLink>; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Majzner+RG%22">Majzner RG</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Mackall+CL%22">Mackall CL</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Diehn+M%22">Diehn M</searchLink>; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA; Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Miklos+DB%22">Miklos DB</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA.<br /><searchLink fieldCode="AU" term="%22Alizadeh+AA%22">Alizadeh AA</searchLink>; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address: arasha@stanford.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101130617%22">Cancer cell</searchLink> [Cancer Cell] 2023 Jan 09; Vol. 41 (1), pp. 210-225.e5. <i>Date of Electronic Publication: </i>2022 Dec 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130617 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-3686 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215356108%22">15356108 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Cell <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36584673
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ccell.2022.12.005
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 210
    Titles:
      – TitleFull: Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sworder BJ
      – PersonEntity:
          Name:
            NameFull: Kurtz DM
      – PersonEntity:
          Name:
            NameFull: Alig SK
      – PersonEntity:
          Name:
            NameFull: Frank MJ
      – PersonEntity:
          Name:
            NameFull: Shukla N
      – PersonEntity:
          Name:
            NameFull: Garofalo A
      – PersonEntity:
          Name:
            NameFull: Macaulay CW
      – PersonEntity:
          Name:
            NameFull: Shahrokh Esfahani M
      – PersonEntity:
          Name:
            NameFull: Olsen MN
      – PersonEntity:
          Name:
            NameFull: Hamilton J
      – PersonEntity:
          Name:
            NameFull: Hosoya H
      – PersonEntity:
          Name:
            NameFull: Hamilton M
      – PersonEntity:
          Name:
            NameFull: Spiegel JY
      – PersonEntity:
          Name:
            NameFull: Baird JH
      – PersonEntity:
          Name:
            NameFull: Sugio T
      – PersonEntity:
          Name:
            NameFull: Carleton M
      – PersonEntity:
          Name:
            NameFull: Craig AFM
      – PersonEntity:
          Name:
            NameFull: Younes SF
      – PersonEntity:
          Name:
            NameFull: Sahaf B
      – PersonEntity:
          Name:
            NameFull: Sheybani ND
      – PersonEntity:
          Name:
            NameFull: Schroers-Martin JG
      – PersonEntity:
          Name:
            NameFull: Liu CL
      – PersonEntity:
          Name:
            NameFull: Oak JS
      – PersonEntity:
          Name:
            NameFull: Jin MC
      – PersonEntity:
          Name:
            NameFull: Beygi S
      – PersonEntity:
          Name:
            NameFull: Hüttmann A
      – PersonEntity:
          Name:
            NameFull: Hanoun C
      – PersonEntity:
          Name:
            NameFull: Dührsen U
      – PersonEntity:
          Name:
            NameFull: Westin JR
      – PersonEntity:
          Name:
            NameFull: Khodadoust MS
      – PersonEntity:
          Name:
            NameFull: Natkunam Y
      – PersonEntity:
          Name:
            NameFull: Majzner RG
      – PersonEntity:
          Name:
            NameFull: Mackall CL
      – PersonEntity:
          Name:
            NameFull: Diehn M
      – PersonEntity:
          Name:
            NameFull: Miklos DB
      – PersonEntity:
          Name:
            NameFull: Alizadeh AA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 01
              Text: 2023 Jan 09
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1878-3686
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer cell
              Type: main
ResultId 1